Stock comparison
ELI LILLY & Co is 399.8x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($1.282 T vs $3.21 B). Compare market value, revenue, profit, margins, filings, and source pages in one place.
Quick answer
LLY is larger
ELI LILLY & Co is 399.8x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($1.282 T vs $3.21 B).
Market value leader
LLY
ELI LILLY & Co is 399.8x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($1.282 T vs $3.21 B).
Revenue leader
LLY
AMLX: $0.00 vs LLY: $65.18B.
Profit leader
LLY
AMLX: -$144.74M vs LLY: $20.64B.
| Metric | AMLX | LLY |
|---|---|---|
| Market cap | $3.21 B | $1.282 T |
| US-listed rank | #1751 | #10 |
| Revenue (latest FY) | $0.00 | $65.18B |
| Net income (latest FY) | -$144.74M | $20.64B |
| Net margin | - | 31.7% |
| P/E (trailing FY) | - | 62.1x |
| SEC filings | 403 | 995 |
Jump from this comparison into the underlying pages for market value, annual fundamentals, and company filing history.
Market cap uses refreshed market data. Revenue, net income, margins, and trailing fiscal-year P/E use annual company facts from filings. If a metric is missing, the source data did not have a clean recent annual value for that company.
ELI LILLY & Co is 399.8x more valuable than Amylyx Pharmaceuticals, Inc. by market capitalization ($1.282 T vs $3.21 B).
In their latest fiscal years, Amylyx Pharmaceuticals, Inc. reported $0.00 in revenue while ELI LILLY & Co reported $65.18B.
Full pages: Amylyx Pharmaceuticals, Inc. and ELI LILLY & Co, or browse the full rankings.